FHM VII, L.P.
CIK 1654632 · last filed 2021-07-20
FHM VII, L.P. is a corporate insider who has filed 2 SEC Form 4 insider transactions across 2 companies since 2017. The most recent filing, for IMGO, was dated Jul 20, 2021. Across all open-market trades the lifetime net is +$63.0M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $71.7M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$71.72M
2
2
$63.00M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Imago BioSciences, Inc. (IMGO) Delisted | 10%+ Owner | 145,918 | $36.01 | $5.25M | $15.00M | 1 | 2021-07-20 |
| ANAB | 10%+ Owner | 1,337,795 | $53.61 | $71.72M | $48.00M | 1 | 2017-01-31 |
Recent Filings
2 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-07-20 | Imago BioSciences, Inc. (IMGO) Delisted | Mixed | +14,856,370 | $15.00M | EDGAR |
| 2017-01-31 | ANAB | Mixed | +28,569,696 | $48.00M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.